Flunarizine arrests hepatitis C virus membrane fusion.

Abstract

H epatitis C virus (HCV) is a blood-borne pathogen that causes widespread chronic liver disease. In an article in the current issue of HEPATOLOGY, Perin et al. identify flunarizine, a clinically approved drug for treating migraine, as an inhibitor of specific HCV genotypes (Fig. 1A). Leveraging several experimental approaches, the authors demonstrate that… (More)
DOI: 10.1002/hep.28224

1 Figure or Table

Topics

  • Blog articles referencing this paper

  • Presentations referencing similar topics